1887

Journal of Medical Microbiology logo

Volume 56, Issue 9

Detection of mixed clarithromycin-resistant and -susceptible using nested PCR and direct sequencing of DNA extracted from faeces Free

Abstract

The major cause of chemotherapy failure in patients with chronic gastritis and peptic ulcers caused by is clarithromycin (CAM) resistance due to a mutation in the 23S rRNA gene. This study describes a non-invasive and accurate method for the detection of mixed CAM-resistant and -susceptible by sequencing of the 23S rRNA gene. Faeces were crushed with beads and the 23S rRNA gene was amplified using a nested PCR on the extracted DNA. Mutation analysis of this gene using this method showed that 20.4 % of patients carried mixed CAM-susceptible (wild type) and -resistant (A2142G or A2143G mutant) . Furthermore, it was found that 66.6 % of patients who had been treated unsuccessfully carried one of these mutations in the 23S rRNA gene (including the mixed type), whilst standard culture detected CAM-resistant isolates in only 22.2 % of patients with unsuccessful treatment. These data suggest that, for successful therapy, the diagnosis method described here would more accurately detect CAM-resistant , including mixed infections.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): CAM, clarithromycin and HpSA, H. pylori stool antigen
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47302-0
2007-09-01
2023-06-05
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/9/1174.html?itemId=/content/journal/jmm/10.1099/jmm.0.47302-0&mimeType=html&fmt=ahah

References

  1. Akiyama H., Watanabe T., Wakabayashi K., Nakade S., Yasui S., Sakata K., Chiba R., Spiegelhalter F., Hino A., Maitani T. 2005; Quantitative detection system for maize sample containing combined-trait genetically modified maize. Anal Chem 77:7421–7428 [CrossRef]
     [Google Scholar]
  2. Alarcon T., Vega A. E., Domingo D., Martinez M. J., Lopez-Brea M. 2003; Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 41:486–499 [CrossRef]
     [Google Scholar]
  3. Asaka M., Satoh K., Sugano K., Sugiyama T., Takahashi S., Fukuda Y., Ota H., Murakami K., Kimura K., Shimoyama T. 2001; Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 6:177–186 [CrossRef]
     [Google Scholar]
  4. Booka M., Okuda M., Shin K., Miyashiro E., Hayashi H., Yamauchi K., Tamura Y., Yoshikawa N. 2005; Polymerase chain reaction-restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample. Helicobacter 10:205–213 [CrossRef]
     [Google Scholar]
  5. CLSI 2002 Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  6. Fontana C., Favaro M., Minelli S., Criscuolo A. A., Pietroiusti A., Galante A., Favalli C. 2002; New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 46:3765–3769 [CrossRef]
     [Google Scholar]
  7. Fontana C., Favaro M., Pietroiusti A., Pistoia E. S., Galante A., Favalli C. 2003; Detection of clarithromycin-resistant Helicobacter pylori in stool samples. J Clin Microbiol 41:3636–3640 [CrossRef]
     [Google Scholar]
  8. Furuta T., Shirai N., Takashima M., Xiao F., Hanai H., Sugimura H., Ohashi K., Ishizaki T., Kaneko E. 2001; Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther 69:158–168 [CrossRef]
     [Google Scholar]
  9. Goodwin C. S., Blincow E. D., Warren J. R., Waters T. E., Sanderson C. R., Easton L. 1985; Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol 38:1127–1131 [CrossRef]
     [Google Scholar]
  10. Graham D. Y., Klein P. D., Evans D. J. Jr, Evans D. G., Alpert L. C., Opekun A. R., Boutton T. W. 1987; Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lanceti1174–1177
     [Google Scholar]
  11. Hoshiya S., Watanabe K., Tokunaga K., Tanaka A., Ninomiya H., Shingaki M., Itoh T., Saito S., Ishida H., Takahashi S. 2000; Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. J Gastroenterol 35:10–14
     [Google Scholar]
  12. Ito M., Tanaka S., Kim S., Tahara K., Kawamura Y., Sumii M., Takehara Y., Hayashi K., Okamoto E. other authors 2005; A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: a multicenter study. J Gastroenterol Hepatol 20:1241–1245 [CrossRef]
     [Google Scholar]
  13. Kato M., Yamaoka Y., Kim J. J., Reddy R., Asaka M., Kashima K., Osato M. S., El-Zaatari F. A., Graham D. Y., Kwon D. H. 2000; Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 44:2214–2216 [CrossRef]
     [Google Scholar]
  14. Khan R., Nahar S., Sultana J., Ahmad M. M., Rahman M. 2004; T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother 48:3567–3569 [CrossRef]
     [Google Scholar]
  15. Kim J. M., Kim J. S., Kim N., Kim S. G., Jung H. C., Song I. S. 2006; Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents 28:6–13 [CrossRef]
     [Google Scholar]
  16. Kuipers E. J. 1997; Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 11 (Suppl. 1):71–88 [CrossRef]
     [Google Scholar]
  17. Kusters J. G., Gerrits M. M., Van Strijp J. A., Vandenbroucke-Grauls C. M. 1997; Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect Immun 65:3672–3679
     [Google Scholar]
  18. Kusters J. G., van Vliet A. H., Kuipers E. J. 2006; Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19:449–490 [CrossRef]
     [Google Scholar]
  19. Leodolter A., Vaira D., Bazzoli F., Schutze K., Hirschl A., Megraud F., Malfertheiner P. 2003; European multicentre validation trial of two new non-invasive tests for the detection of Helicobacter pylori antibodies: urine-based ELISA and rapid urine test. Aliment Pharmacol Ther 18:927–931 [CrossRef]
     [Google Scholar]
  20. Leong R. W., Sung J. J. 2002; Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16:1037–1045 [CrossRef]
     [Google Scholar]
  21. Malfertheiner P., Megraud F., O'Morain C., Hungin A. P., Jones R., Axon A., Graham D. Y., Tytgat G. 2002; Current concepts in the management of Helicobacter pylori infection – the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16:167–180
     [Google Scholar]
  22. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., Tanaka R. 2004; Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 70:167–173 [CrossRef]
     [Google Scholar]
  23. McOrist A. L., Jackson M., Bird A. R. 2002; A comparison of five methods for extraction of bacterial DNA from human faecal samples. J Microbiol Methods 50:131–139 [CrossRef]
     [Google Scholar]
  24. Monteiro L., Gras N., Vidal R., Cabrita J., Megraud F. 2001; Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors. J Microbiol Methods 45:89–94 [CrossRef]
     [Google Scholar]
  25. Morris J. M., Reasonover A. L., Bruce M. G., Bruden D. L., McMahon B. J., Sacco F. D., Berg D. E., Parkinson A. J. 2005; Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J Clin Microbiol 43:3494–3496 [CrossRef]
     [Google Scholar]
  26. Nurgalieva Z. Z., Opekun A. R., Graham D. Y. 2006; Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections. Helicobacter 11:69–74 [CrossRef]
     [Google Scholar]
  27. Prokhorenko I. A., Malakhov A. D., Kozlova A. A., Momynaliev K., Govorun V. M., Korshun V. A. 2006; Phenylethynylpyrene-labeled oligonucleotide probes for excimer fluorescence SNP analysis of 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains. Mutat Res 599:144–151 [CrossRef]
     [Google Scholar]
  28. Rimbara E., Noguchi N., Tanabe M., Kawai T., Matsumoto Y., Sasatsu M. 2005a; Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001. Clin Microbiol Infect 11:307–311 [CrossRef]
     [Google Scholar]
  29. Rimbara E., Noguchi N., Yamaguchi T., Narui K., Kawai T., Sasatsu M. 2005b; Development of a highly sensitive method for detection of clarithromycin-resistant Helicobacter pylori from human feces. Curr Microbiol 51:1–5 [CrossRef]
     [Google Scholar]
  30. Schabereiter-Gurtner C., Hirschl A. M., Dragosics B., Hufnagl P., Puz S., Kovach Z., Rotter M., Makristathis A. 2004; Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J Clin Microbiol 42:4512–4518 [CrossRef]
     [Google Scholar]
  31. Shuber A. P., Ascano J. J., Boynton K. A., Mitchell A., Frierson H. F. Jr, El-Rifai W., Powell S. M. 2002; Accurate, noninvasive detection of Helicobacter pylori DNA from stool samples: potential usefulness for monitoring treatment. J Clin Microbiol 40:262–264 [CrossRef]
     [Google Scholar]
  32. Thomas J. E., Gibson G. R., Darboe M. K., Dale A., Weaver L. T. 1992; Isolation of Helicobacter pylori from human faeces. Lancet 340:1194–1195 [CrossRef]
     [Google Scholar]
  33. Toracchio S., Aceto G. M., Mariani-Costantini R., Battista P., Marzio L. 2004; Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori . Helicobacter 9:396–399 [CrossRef]
     [Google Scholar]
  34. Vaira D., Malfertheiner P., Megraud F., Axon A. T., Deltenre M., Hirschl A. M., Gasbarrini G., O'Morain C., Garcia J. M. other authors 1999; Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet 354:30–33 [CrossRef]
     [Google Scholar]
  35. van Doorn L. J., Glupczynski Y., Kusters J. G., Mégraud F., Midolo P., Maggi-Solcà N., Queiroz D. M., Nouhan N., Stet E., Quint W. G. 2001; Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 45:1500–1504 [CrossRef]
     [Google Scholar]
  36. Wong B. C., Wang W. H., Berg D. E., Fung F. M., Wong K. W., Wong W. M., Lai K. C., Cho C. H., Hui W. M., Lam S. K. 2001; High prevalence of mixed infections by Helicobacter pylori in Hong Kong: metronidazole sensitivity and overall genotype. Aliment Pharmacol Ther 15:493–503 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47302-0
Loading
Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces
J. Med. Microbiol. 56, 1174 (2007); https://doi.org/10.1099/jmm.0.47302-0
/content/journal/jmm/10.1099/jmm.0.47302-0
/content/journal/jmm/10.1099/jmm.0.47302-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error